NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?

Insider buying vs selling

Have Ionis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph H. WenderDirector2025-12-017,429$81.23
$603.49kSell
Joseph H. WenderDirector2025-12-0120,571$80.67
$1.66MSell
Joseph Klein IiiDirector2025-11-254,000$80.00
$320.00kSell
Shannon L. DeversEVP Chief Human Resources Ofc2025-11-2516,777$80.91
$1.36MSell
Shannon L. DeversEVP Chief Human Resources Ofc2025-11-2516,777$53.77
$902.10kBuy
Joseph Klein IiiDirector2025-11-254,000$80.00
$320.00kSell
Joseph Klein IiiDirector2025-11-254,000$80.00
$320.00kSell
Joan E. HermanDirector2025-11-1912,000$72.13
$865.58kSell
Joan E. HermanDirector2025-11-1932,000$72.13
$2.31MSell
Joan E. HermanDirector2025-11-1932,000$63.90
$2.04MBuy

1 of 19

IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IONS insiders and whales buy or sell their stock.

IONS Shareholders

What type of owners hold Ionis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.63%23,689,038$1.89BInstitution
Vanguard Group Inc10.18%16,481,730$1.32BInstitution
T Rowe Price Investment Management Inc8.12%13,156,929$1.05BInstitution
Capital World Investors7.85%12,722,728$1.02BInstitution
Blackrock Inc6.45%10,447,940$834.48MInstitution
Wellington Management Group LLP4.07%6,588,811$526.25MInstitution
Lombard Odier Asset Management Europe Ltd4.01%6,494,000$518.68MInstitution
Bellevue Group Ag3.86%6,244,451$498.74MInstitution
State Street Corp2.71%4,388,651$350.52MInstitution
Deep Track Capital LP2.35%3,808,144$304.16MInstitution

1 of 3

IONS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IONS97.00%3.00%Net SellingNet Selling
ASND100.00%0.00%
SMMT7.35%92.65%Net BuyingNet Buying
MDGL26.01%73.99%Net BuyingNet Selling
MRNA70.28%22.74%Net BuyingNet Buying

Ionis Pharmaceuticals Stock Ownership FAQ

Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals (NASDAQ: IONS) is owned by 108.13% institutional shareholders, 3.35% Ionis Pharmaceuticals insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual Ionis Pharmaceuticals shareholder, owning 2.50M shares representing 1.54% of the company. Lilly Co Eli's Ionis Pharmaceuticals shares are currently valued at $197.43M.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.